/assets/CSL-Behring/HereditaryAngioedema/2304/male/
United Kingdom · Iqvia Solutions Hq Ltd
SHA1: 26981145ed9bb7e7e5c0dc4fafc4441e1e79850c
SHA256: 1e2d966cc9e255736fa6b89dc2b7729cdb2a383ff7fbe2356241a8158894cd11
image/png
12.86KB
2023-04-11 07:24:14 +0000 UTC
/assets/CSL-Behring/HereditaryAngioedema/2304/male/
United Kingdom · Iqvia Solutions Hq Ltd
SHA1: 26981145ed9bb7e7e5c0dc4fafc4441e1e79850c
SHA256: 1e2d966cc9e255736fa6b89dc2b7729cdb2a383ff7fbe2356241a8158894cd11
image/png
12.86KB
2023-04-11 07:24:14 +0000 UTC
/assets/CSL-Behring/HereditaryAngioedema/2304/male/
United Kingdom · Iqvia Solutions Hq Ltd
SHA1: 26981145ed9bb7e7e5c0dc4fafc4441e1e79850c
SHA256: 1e2d966cc9e255736fa6b89dc2b7729cdb2a383ff7fbe2356241a8158894cd11
image/png
12.86KB
2023-04-11 07:24:14 +0000 UTC
/assets/CSL-Behring/HereditaryAngioedema/2304/male/
United Kingdom · Iqvia Solutions Hq Ltd
SHA1: 26981145ed9bb7e7e5c0dc4fafc4441e1e79850c
SHA256: 1e2d966cc9e255736fa6b89dc2b7729cdb2a383ff7fbe2356241a8158894cd11
image/png
12.86KB
2023-04-11 07:24:14 +0000 UTC
/assets/CSL-Behring/HereditaryAngioedema/2304/male/
United Kingdom · Iqvia Solutions Hq Ltd
SHA1: 26981145ed9bb7e7e5c0dc4fafc4441e1e79850c
SHA256: 1e2d966cc9e255736fa6b89dc2b7729cdb2a383ff7fbe2356241a8158894cd11
image/png
12.86KB
2023-04-11 07:24:14 +0000 UTC